TLR2 and tuberculosis: Together with recent work suggesting that the bacterium actively subverts TLR2 activation, our results suggest that modulating the TLR2 pathway, including strategies to collapse heterogeneity within populations of infected cells, may offer precision targets for future host-directed TB therapeutics.